Articles

Science

GPT-6 Release Odds Surge to 41.5% as Market Reassesses OpenAI Timeline

Market icon for Will GPT-6 be released by August 31, 2026?

Will GPT-6 be released by August 31, 2026?

18.0% 41.5%+130.6%

Prediction market odds for GPT-6 public release by August 2026 jumped 23.5 percentage points to 41.5% on $119,000 in volume, signaling a material shift in market expectations about OpenAI's development velocity and near-term AI capability delivery.

Science

Doge-1 Lunar Mission Faces Long Odds for 2026 Launch Window

Market icon for Will the Doge-1 Lunar Mission launch before 2027?

Will the Doge-1 Lunar Mission launch before 2027?

11.6% 11.6%+0.0%

Prediction markets price the Doge-1 satellite launch at just 11.6% probability before end-2026, reflecting significant delays in SpaceX's lunar payload schedule and compressed timeline for mission preparation.

Science

Moon Landing Odds for 2026 Priced at 4.3%, Well Below NASA's Artemis Timeline

Market icon for Human moon landing in 2026?

Human moon landing in 2026?

4.3% 4.3%+0.0%

Prediction markets are assessing a 4.3% probability of a crewed lunar landing by end-2026, reflecting skepticism about accelerated timelines despite billions in space program investment. The low odds underscore the technical and scheduling challenges facing both NASA's Artemis program and competing international efforts.

Science

Retatrutide FDA Approval Odds at 23.5% Through 2026 as Eli Lilly Advances Obesity Drug Trials

Market icon for FDA approves Retatrutide this year?

FDA approves Retatrutide this year?

23.5% 23.5%+0.0%

Prediction markets are pricing retatrutide's chance of FDA approval by end-2026 at 23.5%, reflecting both the drug's clinical promise and the compressed timeline remaining for regulatory clearance. The triple agonist faces a critical development window with multiple indications under investigation.

Science

Prediction Market Sets 5% Odds on Magnitude 10.0+ Earthquake in 2026

Market icon for 10.0 or above earthquake before 2027?

10.0 or above earthquake before 2027?

5.0% 5.0%+0.0%

A prediction market currently prices the probability of a magnitude 10.0 or greater earthquake occurring in 2026 at 5%, reflecting the extreme rarity of such cataclysmic seismic events in the instrumental record.

Science

Odds Lean Toward Quiet Volcanism in 2026 as Market Prices VEI 4+ Eruptions at 46.5%

Market icon for Will there be exactly 0 confirmed VEI 4 or higher volcanic eruptions worldwide in 2026?

Will there be exactly 0 confirmed VEI 4 or higher volcanic eruptions worldwide in 2026?

53.5% 53.5%+0.0%

Prediction markets are assigning a 53.5% probability to zero major volcanic eruptions in 2026, reflecting historical baseline rates but acknowledging meaningful uncertainty around naturally rare but consequential seismic events.

Science

2026 Global Temperature: Market Prices Fifth-Hottest Year as Extremely Unlikely at 0.5%

Market icon for Will 2026 be the fifth-hottest year on record?

Will 2026 be the fifth-hottest year on record?

0.5% 0.5%+0.0%

A prediction market assessing whether 2026 will rank as the fifth-hottest year on record shows near-zero conviction at 0.5% probability, reflecting scientific consensus that the ongoing warming trend makes such a middling placement improbable. The market's assessment hinges on the trajectory of global temperatures and whether 2026 breaks through into the top tier of warmest years.

Science

Doge-1 Lunar Mission Priced as Long Shot, With Only 11.6% Chance of Launch Before 2027

Market icon for Will the Doge-1 Lunar Mission launch before 2027?

Will the Doge-1 Lunar Mission launch before 2027?

11.6% 11.6%+0.0%

Prediction market participants are assigning just 11.6% odds to SpaceX's Doge-1 CubeSat reaching orbit by year-end 2026, reflecting skepticism about the timeline for this low-priority lunar mission despite strong market interest with nearly $785,000 in trading volume.

Science

Retatrutide FDA Approval Odds Hold at 23.5% as Trials Progress Through 2026

Market icon for FDA approves Retatrutide this year?

FDA approves Retatrutide this year?

23.5% 23.5%+0.0%

Prediction markets are pricing a roughly one-in-four chance that Eli Lilly's retatrutide will win FDA approval by end of 2026, reflecting both the drug's clinical promise and the extended timeline remaining for regulatory decisions across multiple indications.

Science

US Alien Confirmation Market Holds at 17.5% Odds Through 2026

Market icon for Will the US confirm that aliens exist before 2027?

Will the US confirm that aliens exist before 2027?

17.5% 17.5%+0.0%

A prediction market assessing the probability of official US government confirmation of extraterrestrial life or technology by end-2026 is trading at 17.5%, with $26 million in volume. The relatively modest odds reflect skepticism about near-term disclosure despite recent government attention to unidentified phenomena.

Science

Volcanic Eruption Market Prices Zero Major Events in 2026 at Slight Majority Odds

Market icon for Will there be exactly 0 confirmed VEI 4 or higher volcanic eruptions worldwide in 2026?

Will there be exactly 0 confirmed VEI 4 or higher volcanic eruptions worldwide in 2026?

53.5% 53.5%+0.0%

Prediction markets currently assess a 53.5% probability that no VEI 4 or higher volcanic eruptions will occur worldwide in 2026, implying roughly even odds between a quiet year and at least one major eruption.

Science

Doge-1 Lunar Mission Faces Long Odds for 2026 Launch, Trading at 11.6%

Market icon for Will the Doge-1 Lunar Mission launch before 2027?

Will the Doge-1 Lunar Mission launch before 2027?

11.6% 11.6%+0.0%

The Doge-1 lunar cubesat mission is trading at just 11.6% probability of launching before 2027, reflecting significant uncertainty around development timelines and SpaceX's launch capacity for this secondary payload.

Science

Moon Landing Odds for 2026 Remain Slim at 4.3% Despite NASA's Artemis Push

Market icon for Human moon landing in 2026?

Human moon landing in 2026?

4.3% 4.3%+0.0%

Prediction markets are pricing a human moon landing in 2026 at just 4.3% probability, reflecting widespread skepticism about NASA's accelerated Artemis timeline despite the agency's official target of a crewed lunar mission by that date.

Science

Retatrutide FDA Approval Odds Remain Low at 23.5% Through 2026

Market icon for FDA approves Retatrutide this year?

FDA approves Retatrutide this year?

23.5% 23.5%+0.0%

Prediction markets are pricing a modest 23.5% probability that Eli Lilly's triple agonist retatrutide will receive FDA approval by end-2026, reflecting skepticism about accelerated timelines despite the drug's broad therapeutic potential across obesity, diabetes, and liver disease.

Science

Alien Confirmation Odds Hold Steady at 17.5% as US Disclosure Debate Persists

Market icon for Will the US confirm that aliens exist before 2027?

Will the US confirm that aliens exist before 2027?

17.5% 17.5%+0.0%

Prediction markets assign a 17.5% probability to official US government confirmation of extraterrestrial life or technology by end-2026, reflecting skepticism about imminent disclosure despite ongoing congressional scrutiny of UAP phenomena.